Edizione | [1st ed. 2021.] |
Pubbl/distr/stampa |
Cham, Switzerland : , : Springer, , [2021]
|
Descrizione fisica |
1 online resource (XIV, 363 p. 19 illus., 16 illus. in color.)
|
Disciplina |
618
|
Soggetto topico |
Oncology
Immunology
Rheumatology
|
ISBN |
3-030-56824-5
|
Formato |
Materiale a stampa ![](img/format/mas.png) |
Livello bibliografico |
Monografia |
Lingua di pubblicazione |
eng
|
Nota di contenuto |
PART 1 - INTRODUCTION -- 1. Cancer Immunology and the evolution of immunotherapy -- 2. Cancer immunotherapy: overview -- 3. Pathogenesis of immune-related adverse events -- PART 2 – IMMUNE-RELATED ADVERSE EVENTS WITH IMMUNE-CHECKPOINT INHIBITORS -- 4. Arthritis -- 5. Polymyalgia rheumatica -- 6. Myositis -- 7. Sicca syndromes -- 8. Sarcoidosis -- 9. Miscellaneous rheumatic syndromes -- 10. Non-rheumatic immune-related adverse events -- 11. Immune-related adverse events with other cancer immunotherapies -- PART 3 – CANCER IMMUNOTHERAPY IN PATIENTS WITH PRE-EXISTING RHEUMATIC DISEASES -- 12. Inflammatory arthritis -- 13. Other rheumatic autoimmune diseases -- 14. Choosing the right therapy -- 15. Risk-benefit considerations -- 16. Patient education and shared-decision making.
|
Record Nr. | UNINA-9910484761403321 |